Anthrax laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 21: | Line 21: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Electrolyte]], [[Renal]] Panel, [[Lactate]] Level''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Electrolyte]], [[Renal]] Panel, [[Lactate]] Level''' | ||
| style="background: #DCDCDC; padding: 5px;"| Decreased [[Sodium]] level<br>Increased [[BUN]] | | style="background: #DCDCDC; padding: 5px;"| Decreased [[Sodium]] level<br>Increased [[BUN]] | ||
| style="background: #DCDCDC; padding: | | style="background: #DCDCDC; padding: 0px;"| | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver]] Enzymes, Serum [[Albumin]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Liver]] Enzymes, Serum [[Albumin]]''' | ||
| style="background: #DCDCDC; padding: 5px;"|Elevated [[transaminase]] levels<br>[[hypoalbuminemia]] | | style="background: #DCDCDC; padding: 5px;"|Elevated [[transaminase]] levels<br>[[hypoalbuminemia]] | ||
| style="background: #DCDCDC; padding: | | style="background: #DCDCDC; padding: 0px;"| | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[PT]], [[PTT]], [[D-dimer]], [[Fibrinogen]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[PT]], [[PTT]], [[D-dimer]], [[Fibrinogen]]''' | ||
| Line 33: | Line 33: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[C-Reactive Protein]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[C-Reactive Protein]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| Characterization of Inflammatory Response<br>Typically low [[CRP]] in injection [[anthrax]] | | style="background: #DCDCDC; padding: 5px;"| Characterization of Inflammatory Response<br>Typically low [[CRP]] in injection [[anthrax]] | ||
| style="background: #DCDCDC; padding: | | style="background: #DCDCDC; padding: 0px;"| | ||
|- | |- | ||
Revision as of 23:31, 16 July 2014
|
Anthrax Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anthrax laboratory findings On the Web |
|
American Roentgen Ray Society Images of Anthrax laboratory findings |
|
Risk calculators and risk factors for Anthrax laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
The following tests are used in the diagnosis and monitoring of systemic anthrax:[1]
| Test | Initial Findings | Serial Monitoring |
|---|---|---|
| CBC | Hemoconcentration Possible Thrombocytopenia Leukocyte count commonly normal |
Anemia Thrombocytopenia Leukocytosis (late in disease) |
| Electrolyte, Renal Panel, Lactate Level | Decreased Sodium level Increased BUN |
|
| Liver Enzymes, Serum Albumin | Elevated transaminase levels hypoalbuminemia |
|
| PT, PTT, D-dimer, Fibrinogen | Normal PT/PTT does not exclude DIC or coagulopathy | Low threshold for hypercoagulability workup: Haptoglobin LDH Fibrin split products ADAMTS 13 if hemolytic anemia |
| C-Reactive Protein | Characterization of Inflammatory Response Typically low CRP in injection anthrax |
|
| Gram stain, Cultures, Toxic Assays | Blood Serum CSF Pleural fluid Ascites Wound exudate Bronchial exudate |
Cultures usually negative after antibiotics Toxins may be detected |
References
- ↑ Hendricks, Katherine A.; Wright, Mary E.; Shadomy, Sean V.; Bradley, John S.; Morrow, Meredith G.; Pavia, Andy T.; Rubinstein, Ethan; Holty, Jon-Erik C.; Messonnier, Nancy E.; Smith, Theresa L.; Pesik, Nicki; Treadwell, Tracee A.; Bower, William A. (2014). "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults". Emerging Infectious Diseases. 20 (2). doi:10.3201/eid2002.130687. ISSN 1080-6040.